Pfizer Inc (NYSE:PFE)

34.28
Delayed Data
As of May 22
 -0.08 / -0.23%
Today’s Change
27.51
Today|||52-Week Range
35.53
+10.05%
Year-to-Date
3 Stocks Poised to Grow in the Schizophrenia Market - Analyst Blog
May 22 / Zacks.com
GlycoMimetics' Leukemia Drug Gets Orphan Status in U.S. - Analyst Blog
May 15 / Zacks.com
Benzinga's M&A Chatter for Thursday May 21, 2015
May 21 / Benzinga
The drugs to watch in fight against cancer
May 14 / FT.com
The Most Popular Stocks Held By 4 Different Generations Of Investors
May 21 / Benzinga
Roche Reports Encouraging Data on Lung Cancer Drugs - Analyst Blog
May 14 / Zacks.com
MannKind, Front and Center: The Best Product Doesnbt Always Equal the Best Stock
May 21 / MotleyFool.com
How a Strong Dollar Affects Pharmaceutical Stocks
May 14 / MotleyFool.com
3 Big Pharmaceutical Stocks to Buy Right Now
May 21 / TheStreet.com
Better Dividend Stock: Pfizer, Inc. or GlaxoSmithKline plc?
May 13 / MotleyFool.com
Sarepta to Finish Eteplirsen Regulatory Filing by Mid-15 - Analyst Blog
May 20 / Zacks.com
Pfizer Acquires Stake in Dutch Biopharmaceutical Company - Analyst Blog
May 12 / Zacks.com
What Is the S&P 500 Index?
May 20 / MotleyFool.com
5 Largest Markets for Pharmaceuticals
May 12 / MotleyFool.com
Why Shares of Sarepta Therapeutics Skyrocketed Today
May 20 / MotleyFool.com
Top 50 US boardroom hoarders sit on $1tn in cash
May 10 / FT.com
Merck KGaA Q1 Earnings Fall Y/Y, 2015 Sales View Retained - Analyst Blog
May 19 / Zacks.com
European drugmakers lifted by weak euro
Apr 30 / FT.com
The 30 Dow Jones Stocks
May 18 / MotleyFool.com
Taubman lures more dealmakers to boutique
Apr 29 / FT.com
Immunomedics' Drug Gets Fast Track Status for Lung Cancer - Analyst Blog
May 18 / Zacks.com
Investors sour on Coach turnround efforts
Apr 28 / FT.com
Endo to buy Par from TPG Capital in in $8bn deal
May 18 / FT.com
Pfizer cuts forecasts as strong dollar bites
Apr 28 / FT.com
4 Reasons Why MannKind Could Succeed Where Pfizer Failed
May 17 / MotleyFool.com
Stocks: 5 things to know before the open
Apr 28 / CNNMoney.com
Big Pharma Stocks: Where to Invest Your Money Now
May 17 / MotleyFool.com
BP shareholders need protecting from David Cameron
Apr 27 / FT.com
The Botox initiation of Brent Saunders, Actavis chief executive
May 17 / FT.com
No end in sight to wave of pharma dealmaking
Apr 26 / FT.com
Could an HIV/AIDS Vaccine Be a Reality By the End of the Decade?
May 16 / MotleyFool.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account